The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05042128 · UNKNOWN
Trial details
- NCT number
- NCT05042128
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2025-06-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.